PEG
50
-3
AMZN
50
-5
BF.B
59
-2
CVX
25
-4
PNC
76
-6
MAS
60
-2
AAP
12
-14
FFIV
54
-2
ED
39
3
KO
46
5
AIZ
59
-2
EOG
49
-3
GILD
47
-5
VIX
25
3
ZBH
44
-3
IVZ
68
-5
CVS
39
-11
LEG
62
-2
LMT
62
2
FITB
76
-4
PEG
50
-3
AMZN
50
-5
BF.B
59
-2
CVX
25
-4
PNC
76
-6
MAS
60
-2
AAP
12
-14
FFIV
54
-2
ED
39
3
KO
46
5
AIZ
59
-2
EOG
49
-3
GILD
47
-5
VIX
25
3
ZBH
44
-3
IVZ
68
-5
CVS
39
-11
LEG
62
-2
LMT
62
2
FITB
76
-4
Financhill
Back

Calvert US Mid-Cap Core Responsible Index ETF Vs. Nektar Therapeutics Industry Stock Comparison

Buy
54

CVMC
Calvert US Mid-Cap Core Responsible Index ETF

Last Price:
$65.00
Seasonality Move:
2.92%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$53.62
Seasonality Move:
11.58%
Buy
54
Calvert US Mid-Cap Core Responsible Index ETF (CVMC) is a Buy

Is Calvert US Mid-Cap Core Responsible Index ETF a Buy, Sell or Hold?

  • The current Calvert US Mid-Cap Core Responsible Index ETF [CVMC] share price is $65.00. The Score for CVMC is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • CVMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CVMC Stock Price Chart

What is Calvert US Mid-Cap Core Responsible Index ETF's stock price today?

  • The Calvert US Mid-Cap Core Responsible Index ETF share price today is $65.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVMC is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

CVMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 58.57 Buy
Chaikin Money Flow: -2565 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.4 - 64.76) Buy
Bollinger Bands (100): (62.19 - 64.07) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

CVMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.7 Buy
20-day SMA: 63.59 Buy
50-day SMA: 63.46 Buy
200-day SMA: 60.59 Buy
8-day EMA: 64.72 Buy
20-day EMA: 64.08 Buy
50-day EMA: 63.54 Buy
200-day EMA: 61.63 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Calvert US Mid-Cap Core Responsible Index ETF Earnings Growth & CVMC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Calvert US Mid-Cap Core Responsible Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):